PortfoliosLab logoPortfoliosLab logo
Zimmer Biomet Holdings, Inc. (ZBH)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US98956P1021
CUSIP
98956P102
IPO Date
Jul 25, 2001

Highlights

EPS (TTM)
$4.27
PE Ratio
21.16
PEG Ratio
0.37
Total Revenue (TTM)
$2.24B
Gross Profit (TTM)
$1.27B
EBITDA (TTM)
$1.76B
Year Range
$84.59 - $114.44
Target Price
$108.00
ROA (TTM)
2.45%
ROE (TTM)
3.99%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Zimmer Biomet Holdings, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Zimmer Biomet Holdings, Inc. (ZBH) has returned 0.83% so far this year and -19.27% over the past 12 months. Over the last ten years, ZBH has returned -0.60% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Zimmer Biomet Holdings, Inc.

1D
2.31%
1M
-7.90%
YTD
0.83%
6M
-7.71%
1Y
-19.27%
3Y*
-10.42%
5Y*
-9.50%
10Y*
-0.60%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 25, 2001, ZBH's average daily return is +0.04%, while the average monthly return is +0.69%. At this rate, your investment would double in approximately 8.4 years.

Historically, 53% of months were positive and 47% were negative. The best month was Apr 2009 with a return of +20.5%, while the worst month was Oct 2008 at -28.1%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.

On a daily basis, ZBH closed higher 51% of trading days. The best single day was Mar 24, 2020 with a return of +15.6%, while the worst single day was Nov 5, 2025 at -15.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-3.17%13.06%-7.90%0.83%
20253.64%-4.71%8.73%-8.95%-10.56%-0.78%0.48%15.77%-6.94%2.09%-3.02%-7.55%-14.03%
20243.20%-0.99%6.33%-8.86%-4.27%-5.54%2.60%3.69%-6.30%-0.95%4.84%-5.56%-12.46%
2023-0.13%-2.72%4.50%7.15%-8.02%14.53%-5.12%-13.77%-5.59%-6.96%11.40%4.84%-3.81%
2022-3.16%3.39%3.77%-5.59%-0.45%-12.41%5.07%-3.69%-1.44%8.42%5.96%6.36%4.24%
2021-0.27%6.11%-1.68%10.67%-4.98%-4.32%1.62%-7.94%-2.56%-2.21%-16.43%6.42%-17.02%

Benchmark Metrics

Zimmer Biomet Holdings, Inc. has an annualized alpha of 2.45%, beta of 0.76, and R² of 0.27 versus S&P 500 Index. Calculated based on daily prices since July 26, 2001.

  • This stock participated in 89.33% of S&P 500 Index downside but only 80.47% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.27 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
2.45%
Beta
0.76
0.27
Upside Capture
80.47%
Downside Capture
89.33%

Return for Risk

Risk / Return Rank

ZBH ranks 15 for risk / return — in the bottom 15% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


ZBH Risk / Return Rank: 1515
Overall Rank
ZBH Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
ZBH Sortino Ratio Rank: 1616
Sortino Ratio Rank
ZBH Omega Ratio Rank: 1515
Omega Ratio Rank
ZBH Calmar Ratio Rank: 1313
Calmar Ratio Rank
ZBH Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and compare them to a chosen benchmark (S&P 500 Index).


ZBHBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.62

0.90

-1.52

Sortino ratio

Return per unit of downside risk

-0.66

1.39

-2.04

Omega ratio

Gain probability vs. loss probability

0.90

1.21

-0.31

Calmar ratio

Return relative to maximum drawdown

-0.78

1.40

-2.18

Martin ratio

Return relative to average drawdown

-1.16

6.61

-7.76

Explore ZBH risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Zimmer Biomet Holdings, Inc. provided a 1.06% dividend yield over the last twelve months, with an annual payout of $0.96 per share. The company has been increasing its dividends for 13 consecutive years.


0.60%0.70%0.80%0.90%1.00%1.10%$0.00$0.20$0.40$0.60$0.80$1.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.96$0.96$0.96$0.96$0.96$0.93$0.93$0.93$0.93$0.93$0.93$0.85

Dividend yield

1.06%1.07%0.91%0.79%0.75%0.76%0.62%0.64%0.93%0.80%0.93%0.86%

Monthly Dividends

The table displays the monthly dividend distributions for Zimmer Biomet Holdings, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.24$0.24
2025$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.96
2024$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.96
2023$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.96
2022$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.96
2021$0.00$0.00$0.23$0.00$0.00$0.23$0.00$0.00$0.23$0.00$0.00$0.23$0.93

Dividend Yield & Payout


Dividend Yield

Zimmer Biomet Holdings, Inc. has a dividend yield of 1.06%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Zimmer Biomet Holdings, Inc. has a payout ratio of 33.73%, which is quite average when compared to the overall market. This suggests that Zimmer Biomet Holdings, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Zimmer Biomet Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zimmer Biomet Holdings, Inc. was 65.03%, occurring on Mar 9, 2009. Recovery took 1182 trading sessions.

The current Zimmer Biomet Holdings, Inc. drawdown is 45.62%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-65.03%Apr 27, 2007470Mar 9, 20091182Nov 14, 20131652
-49.73%Feb 18, 202022Mar 18, 2020203Jan 6, 2021225
-48.59%Apr 30, 20211192Jan 28, 2026
-40.49%Jul 8, 2004514Jul 20, 2006185Apr 17, 2007699
-26.23%Aug 10, 201668Nov 14, 2016166Jul 14, 2017234

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Zimmer Biomet Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Zimmer Biomet Holdings, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ZBH, comparing it with other companies in the Medical Devices industry. Currently, ZBH has a P/E ratio of 21.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ZBH compared to other companies in the Medical Devices industry. ZBH currently has a PEG ratio of 0.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ZBH relative to other companies in the Medical Devices industry. Currently, ZBH has a P/S ratio of 5.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items